Update on COVID-19 research at Helix
Data from Helix's research community is helping scientists around the world, including a recent finding published in the New England Journal of Medicine.
Beyond the cough: symptoms and trends from a COVID-19 survey
Our team of researchers are currently working through the data, but we have already found some interesting insights in our collection of survey responses, and we’ve contributed our findings to a worldwide research effort, consisting...
Saliva-based COVID-19 testing is less sensitive than nasopharyngeal swabs in the community setting
Helix researchers, along with collaborators from Renown Health and UC San Diego, found that, relative to nasopharyngeal swabs, the sensitivity of saliva was approximately 30% lower in a community-based diagnostic cohort and 50% lower...
Why Helix researchers are studying DNA to learn about COVID-19
Over the next several days, Helix researchers will be reaching out to hundreds of thousands of people—each of them having already had their DNA sequenced by Helix—with a short survey. The survey collects information about...
Exploring the influence of genetics on COVID-19
Helix researchers to leverage user input and exome-sequencing data to understand COVID-19 risk and severity The spread of the novel SARS-CoV-2 coronavirus has led to the unfolding COVID-19 pandemic. In addition to demonstrating a high...
Revealing variants in SARS-CoV-2 interaction domain of ACE2 and loss of function intolerance through analysis of >200,000 exomes
Our analysis suggests that variants in the ACE2 gene--particularly those in the regions that interact with the SARs-COV-2 virus--have the potential to show important associations with COVID-19 susceptibility and resistance.
